MedTrace Logo

Terraflora Daily Care and Gastrointestinal Health

NCT07355634 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-11

No results posted yet for this study

Summary

A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.

Conditions

  • Gastrointestinal

Interventions

DIETARY_SUPPLEMENT

Synbiotic Dietary Supplement

12 weeks of supplementation with Enviromedica - Terraflora Daily Care

DIETARY_SUPPLEMENT

Placebo

Placebo capsule

Sponsors & Collaborators

  • OvationLab

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-12
Primary Completion
2026-06-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07355634 on ClinicalTrials.gov